BioCentury
ARTICLE | Clinical News

Newron Phase II neuropathic pain data

October 26, 2004 7:00 AM UTC

Newron (Milan, Italy) said preliminary data from a Phase II trial in 18 neuropathic pain patients showed that ralfinamide significantly improved pain as measured by the Visual Analog Scale (VAS) by 26...